We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.74%
2 Healthcare 2.42%
3 Financials 2.31%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSMX
12451
PUT
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
$71K ﹤0.01%
+13,500
New +$74.6K
JCICW
12452
DELISTED
Jack Creek Investment Corp. Warrants
JCICW
$71K ﹤0.01%
329,460
-84,177
-20% -$28K
MACK
12453
PUT
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$71K ﹤0.01%
+11,300
New +$63.5K
ASMB icon
12454
CALL
Assembly Biosciences
ASMB
$671M
$70K ﹤0.01%
2,825
+1,492
+112% +$32K
KULR icon
12455
PUT
KULR Technology Group
KULR
$122M
$70K ﹤0.01%
4,038
-3,437
-46% -$63.7K
SCNI
12456
Scinai Immunotherapeutics
SCNI
$1.25M
$70K ﹤0.01%
+422
New +$61.3K
SNCR
12457
PUT
DELISTED
Synchronoss Technologies
SNCR
$70K ﹤0.01%
4,467
+634
+17% +$10.8K
WYY icon
12458
PUT
WidePoint Corp
WYY
$94.5M
$70K ﹤0.01%
18,500
+7,900
+75% +$32.1K
CONXW
12459
DELISTED
CONX Corp. Warrant
CONXW
$70K ﹤0.01%
167,082
-332,918
-67% -$176K
PV.WS
12460
DELISTED
Primavera Capital Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PV.WS
$70K ﹤0.01%
175,001
SREV
12461
CALL
DELISTED
ServiceSource International, Inc.
SREV
$70K ﹤0.01%
53,700
-29,400
-35% -$34K
AEG icon
12462
CALL
Aegon
AEG
$14B
$69K ﹤0.01%
+13,697
New +$69.2K
BNZIW
12463
DELISTED
Banzai International Warrant
BNZIW
$69K ﹤0.01%
300,047
ELDN icon
12464
PUT
Eledon Pharmaceuticals
ELDN
$288M
$69K ﹤0.01%
+17,500
New +$67.8K
EVGN icon
12465
PUT
Evogene
EVGN
$9.49M
$69K ﹤0.01%
5,340
-4,830
-47% -$65.1K
LUCD icon
12466
Lucid Diagnostics
LUCD
$197M
$69K ﹤0.01%
+20,495
New +$74.9K
VANI icon
12467
CALL
Vivani Medical
VANI
$126M
$69K ﹤0.01%
16,100
-1,000
-6% -$4.2K
YARW
12468
CALL
Yarrow Bioscience
YARW
$113M
$69K ﹤0.01%
117
+23
+24% +$13.7K
LILM
12469
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
$69K ﹤0.01%
17,336
-2,623
-13% -$12.1K
TRONW
12470
DELISTED
Corner Growth Acquisition Corp. 2 Warrants
TRONW
$69K ﹤0.01%
400,330
+331
+0.1% +$109
TBCPW
12471
DELISTED
Thunder Bridge Capital Partners III Inc. Warrant
TBCPW
$69K ﹤0.01%
130,291
HEXO
12472
PUT
DELISTED
HEXO Corp. Common Shares
HEXO
$69K ﹤0.01%
7,893
+3,184
+68% +$27.1K
CNCE
12473
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$69K ﹤0.01%
20,393
-54,891
-73% -$174K
MBIO icon
12474
CALL
Mustang Bio
MBIO
$4.5M
$68K ﹤0.01%
90
+33
+58% +$27.1K
RLGT icon
12475
CALL
Radiant Logistics
RLGT
$408M
$68K ﹤0.01%
10,600
-3,400
-24% -$22.5K

Similar funds

Ken Griffin's Q1 2022 Portfolio in Review

As of Q1 2022, Ken Griffin held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Ken Griffin deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Ken Griffin's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Ken Griffin's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Ken Griffin fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Ken Griffin's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Ken Griffin opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Ken Griffin's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.